{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T03:01:25Z","timestamp":1789095685000,"version":"build-2803163510"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,2,4]],"date-time":"2021-02-04T00:00:00Z","timestamp":1612396800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,2,4]],"date-time":"2021-02-04T00:00:00Z","timestamp":1612396800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["EY027785"],"award-info":[{"award-number":["EY027785"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["EY030413"],"award-info":[{"award-number":["EY030413"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001818","name":"Research to Prevent Blindness","doi-asserted-by":"publisher","award":["Career Development Award"],"award-info":[{"award-number":["Career Development Award"]}],"id":[{"id":"10.13039\/100001818","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Roger and Dorothy Hirl Research Fund"},{"name":"National Eye Institute Diversity Supplement","award":["EY027785-03S1"],"award-info":[{"award-number":["EY027785-03S1"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Distinct mutations in the secreted extracellular matrix protein, fibulin-3 (F3), have been associated with a number of ocular diseases ranging from primary open angle glaucoma to cuticular age-related macular degeneration to a rare macular dystrophy, Malattia Leventinese (ML). The R345W F3 mutation that causes ML leads to F3 misfolding, inefficient secretion and accumulation at higher intracellular steady state levels in cultured cells. Herein, we determined whether fifteen other clinically-identified F3 mutations also led to similar levels of misfolding and secretion defects, which might provide insight into their potential pathogenicity. Surprisingly, we found that only a single F3 variant, L451F, presented with a significant secretion defect (69.5\u2009\u00b1\u20092.4% of wild-type (WT) F3 levels) and a corresponding increase in intracellular levels (226.8\u2009\u00b1\u200925.4% of WT F3 levels). Upon follow-up studies, when this conserved residue (L451) was mutated to a charged (Asp or Arg) or bulky (Pro, Trp, Tyr) residue, F3 secretion was also compromised, indicating the importance of small side chains (Leu, Ala, or Gly) at this residue. To uncover potential inherent F3 instability not easily observed under typical culture conditions, we genetically eliminated the sole stabilizing N-linked glycosylation site (N249) from select clinically-identified F3 mutants. This removal exacerbated R345W and L451F secretion defects (19.8\u2009\u00b1\u20093.0% and 12.4\u2009\u00b1\u20091.2% of WT F3 levels, respectively), but also revealed a previously undiscovered secretion defect in another C-terminal variant, Y397H (42.0\u2009\u00b1\u200910.1% of WT F3 levels). Yet, glycan removal did not change the relative secretion of the N-terminal mutants tested (D49A, R140W, I220F). These results highlight the uniqueness and molecular similarities between the R345W and L451F variants and also suggest that previously identified disease-associated mutations (e.g., R140W) are indistinguishable from WT with respect to secretion, hinting that they may lead to disease by an alternative mechanism.<\/jats:p>","DOI":"10.1038\/s41598-020-79570-x","type":"journal-article","created":{"date-parts":[[2021,2,4]],"date-time":"2021-02-04T11:08:10Z","timestamp":1612436890000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Clinically-identified C-terminal mutations in fibulin-3 are prone to misfolding and destabilization"],"prefix":"10.1038","volume":"11","author":[{"given":"DaNae R.","family":"Woodard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emi","family":"Nakahara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John D.","family":"Hulleman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,2,4]]},"reference":[{"key":"79570_CR1","doi-asserted-by":"publisher","first-page":"e1164","DOI":"10.1016\/S2214-109X(17)30412-6","volume":"5","author":"C Sabanayagam","year":"2017","unstructured":"Sabanayagam, C. & Cheng, C. Y. Global causes of vision loss in 2015: are we on track to achieve the Vision 2020 target?. Lancet Glob. Health 5, e1164\u2013e1165 (2017).","journal-title":"Lancet Glob. Health"},{"key":"79570_CR2","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1001\/jamaophthalmol.2016.1284","volume":"134","author":"R Varma","year":"2016","unstructured":"Varma, R. et al. Visual impairment and blindness in adults in the United States: demographic and geographic variations From 2015 to 2050. JAMA Ophthalmol. 134, 802\u2013809 (2016).","journal-title":"JAMA Ophthalmol."},{"key":"79570_CR3","doi-asserted-by":"publisher","first-page":"16003","DOI":"10.1038\/npjamd.2016.3","volume":"2","author":"JB Lin","year":"2016","unstructured":"Lin, J. B., Tsubota, K. & Apte, R. S. A glimpse at the aging eye. NPJ Aging Mech. Dis. 2, 16003 (2016).","journal-title":"NPJ Aging Mech. Dis."},{"key":"79570_CR4","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1136\/pgmj.2005.040857","volume":"82","author":"SM Salvi","year":"2006","unstructured":"Salvi, S. M., Akhtar, S. & Currie, Z. Ageing changes in the eye. Postgrad. Med. J. 82, 581\u2013587 (2006).","journal-title":"Postgrad. Med. J."},{"key":"79570_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1167\/iovs.13-12993","volume":"54","author":"GJ Chader","year":"2013","unstructured":"Chader, G. J. & Taylor, A. Preface: the aging eye: normal changes, age-related diseases, and sight-saving approaches. Investig. Ophthalmol. Vis. Sci. 54, 1\u20134 (2013).","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"79570_CR6","doi-asserted-by":"publisher","first-page":"e106","DOI":"10.1016\/S2214-109X(13)70145-1","volume":"2","author":"WL Wong","year":"2014","unstructured":"Wong, W. L. et al. Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis. Lancet Glob. Health 2, e106-116 (2014).","journal-title":"Lancet Glob. Health"},{"key":"79570_CR7","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1146\/annurev.genom.9.081307.164350","volume":"10","author":"A Swaroop","year":"2009","unstructured":"Swaroop, A., Chew, E. Y., Rickman, C. B. & Abecasis, G. R. Unraveling a multifactorial late-onset disease: from genetic susceptibility to disease mechanisms for age-related macular degeneration. Annu. Rev. Genom. Hum. Genet. 10, 19\u201343 (2009).","journal-title":"Annu. Rev. Genom. Hum. Genet."},{"key":"79570_CR8","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.mam.2012.04.005","volume":"33","author":"I Bhutto","year":"2012","unstructured":"Bhutto, I. & Lutty, G. Understanding age-related macular degeneration (AMD): relationships between the photoreceptor\/retinal pigment epithelium\/Bruch\u2019s membrane\/choriocapillaris complex. Mol. Aspects Med. 33, 295\u2013317 (2012).","journal-title":"Mol. Aspects Med."},{"key":"79570_CR9","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1080\/07853890600946724","volume":"38","author":"KM Gehrs","year":"2006","unstructured":"Gehrs, K. M., Anderson, D. H., Johnson, L. V. & Hageman, G. S. Age-related macular degeneration\u2013emerging pathogenetic and therapeutic concepts. Ann. Med. 38, 450\u2013471 (2006).","journal-title":"Ann. Med."},{"key":"79570_CR10","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.neuron.2012.06.018","volume":"75","author":"J Ambati","year":"2012","unstructured":"Ambati, J. & Fowler, B. J. Mechanisms of age-related macular degeneration. Neuron 75, 26\u201339 (2012).","journal-title":"Neuron"},{"key":"79570_CR11","doi-asserted-by":"publisher","first-page":"413","DOI":"10.2147\/OPTH.S2151","volume":"2","author":"VL Bonilha","year":"2008","unstructured":"Bonilha, V. L. Age and disease-related structural changes in the retinal pigment epithelium. Clin. Ophthalmol. 2, 413\u2013424 (2008).","journal-title":"Clin. Ophthalmol."},{"key":"79570_CR12","doi-asserted-by":"publisher","first-page":"4481","DOI":"10.1167\/iovs.03-0436","volume":"44","author":"PT Johnson","year":"2003","unstructured":"Johnson, P. T. et al. Drusen-associated degeneration in the retina. Investig. Ophthalmol. Vis. Sci. 44, 4481\u20134488 (2003).","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"79570_CR13","doi-asserted-by":"publisher","first-page":"519","DOI":"10.12688\/f1000research.10998.1","volume":"6","author":"S Bahadorani","year":"2017","unstructured":"Bahadorani, S. & Singer, M. Recent advances in the management and understanding of macular degeneration. F1000Res 6, 519 (2017).","journal-title":"F1000Res"},{"key":"79570_CR14","first-page":"103","volume":"1","author":"JF Girmens","year":"2012","unstructured":"Girmens, J. F., Sahel, J. A. & Marazova, K. Dry age-related macular degeneration: a currently unmet clinical need. Intractable Rare Dis. Res. 1, 103\u2013114 (2012).","journal-title":"Intractable Rare Dis. Res."},{"key":"79570_CR15","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/j.ophtha.2004.10.047","volume":"112","author":"TE Clemons","year":"2005","unstructured":"Clemons, T. E. et al. Risk factors for the incidence of advanced age-related macular degeneration in the age-related eye disease study (AREDS) AREDS report no. 19. Ophthalmology 112, 533\u2013539 (2005).","journal-title":"Ophthalmology"},{"key":"79570_CR16","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1038\/sj.eye.6701978","volume":"19","author":"J Thornton","year":"2005","unstructured":"Thornton, J. et al. Smoking and age-related macular degeneration: a review of association. Eye (Lond.) 19, 935\u2013944 (2005).","journal-title":"Eye (Lond.)"},{"key":"79570_CR17","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1016\/j.ajo.2003.11.069","volume":"137","author":"R Klein","year":"2004","unstructured":"Klein, R., Peto, T., Bird, A. & Vannewkirk, M. R. The epidemiology of age-related macular degeneration. Am. J. Ophthalmol. 137, 486\u2013495 (2004).","journal-title":"Am. J. Ophthalmol."},{"key":"79570_CR18","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1038\/9722","volume":"22","author":"EM Stone","year":"1999","unstructured":"Stone, E. M. et al. A single EFEMP1 mutation associated with both Malattia Leventinese and Doyne honeycomb retinal dystrophy. Nat. Genet. 22, 199\u2013202 (1999).","journal-title":"Nat. Genet."},{"key":"79570_CR19","doi-asserted-by":"publisher","first-page":"3085","DOI":"10.1167\/iovs.05-1600","volume":"47","author":"M Michaelides","year":"2006","unstructured":"Michaelides, M. et al. Maculopathy due to the R345W substitution in fibulin-3: distinct clinical features, disease variability, and extent of retinal dysfunction. Investig. Ophthalmol. Vis. Sci. 47, 3085\u20133097 (2006).","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"79570_CR20","doi-asserted-by":"publisher","first-page":"13067","DOI":"10.1073\/pnas.202491599","volume":"99","author":"LY Marmorstein","year":"2002","unstructured":"Marmorstein, L. Y. et al. Aberrant accumulation of EFEMP1 underlies drusen formation in Malattia Leventinese and age-related macular degeneration. Proc. Natl. Acad. Sci. USA 99, 13067\u201313072 (2002).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"79570_CR21","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s00439-010-0904-6","volume":"129","author":"KJ Meyer","year":"2011","unstructured":"Meyer, K. J. et al. Genome-wide analysis of copy number variants in age-related macular degeneration. Hum. Genet. 129, 91\u2013100 (2011).","journal-title":"Hum. Genet."},{"key":"79570_CR22","doi-asserted-by":"publisher","first-page":"e0152047","DOI":"10.1371\/journal.pone.0152047","volume":"11","author":"MR Duvvari","year":"2016","unstructured":"Duvvari, M. R. et al. Whole exome sequencing in patients with the cuticular drusen subtype of age-related macular degeneration. PLoS ONE 11, e0152047 (2016).","journal-title":"PLoS ONE"},{"key":"79570_CR23","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/978-3-319-17121-0_21","volume":"854","author":"JD Hulleman","year":"2016","unstructured":"Hulleman, J. D. Malattia leventinese\/doyne honeycomb retinal dystrophy: similarities to age-related macular degeneration and potential therapies. Adv. Exp. Med. Biol. 854, 153\u2013158 (2016).","journal-title":"Adv. Exp. Med. Biol."},{"key":"79570_CR24","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.exer.2009.09.018","volume":"90","author":"Y Zhang","year":"2010","unstructured":"Zhang, Y. & Marmorstein, L. Y. Focus on molecules: fibulin-3 (EFEMP1). Exp. Eye Res. 90, 374\u2013375 (2010).","journal-title":"Exp. Eye Res."},{"key":"79570_CR25","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1038\/nrm1130","volume":"4","author":"R Timpl","year":"2003","unstructured":"Timpl, R., Sasaki, T., Kostka, G. & Chu, M. L. Fibulins: a versatile family of extracellular matrix proteins. Nat. Rev. 4, 479\u2013489 (2003).","journal-title":"Nat. Rev."},{"key":"79570_CR26","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1007\/s00109-020-01974-z","volume":"98","author":"S Daniel","year":"2020","unstructured":"Daniel, S. et al. Fibulin-3 knockout mice demonstrate corneal dysfunction but maintain normal retinal integrity. J. Mol. Med. 98, 1639\u20131656 (2020).","journal-title":"J. Mol. Med."},{"key":"79570_CR27","doi-asserted-by":"publisher","first-page":"4765","DOI":"10.1091\/mbc.e11-08-0695","volume":"22","author":"JD Hulleman","year":"2011","unstructured":"Hulleman, J. D., Kaushal, S., Balch, W. E. & Kelly, J. W. Compromised mutant EFEMP1 secretion associated with macular dystrophy remedied by proteostasis network alteration. Mol. Biol. Cell 22, 4765\u20134775 (2011).","journal-title":"Mol. Biol. Cell"},{"key":"79570_CR28","doi-asserted-by":"publisher","first-page":"3973","DOI":"10.1167\/iovs.05-0070","volume":"46","author":"CN Roybal","year":"2005","unstructured":"Roybal, C. N., Marmorstein, L. Y., Vander Jagt, D. L. & Abcouwer, S. F. Aberrant accumulation of fibulin-3 in the endoplasmic reticulum leads to activation of the unfolded protein response and VEGF expression. Investig. Ophthalmol. Vis. Sci. 46, 3973\u20133979 (2005).","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"79570_CR29","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1177\/1087057112469405","volume":"18","author":"JD Hulleman","year":"2013","unstructured":"Hulleman, J. D., Brown, S. J., Rosen, H. & Kelly, J. W. A high-throughput cell-based Gaussia luciferase reporter assay for identifying modulators of fibulin-3 secretion. J. Biomol. Screen. 18, 647\u2013658 (2013).","journal-title":"J. Biomol. Screen."},{"key":"79570_CR30","doi-asserted-by":"publisher","first-page":"4548","DOI":"10.1096\/fj.11-202861","volume":"26","author":"JD Hulleman","year":"2012","unstructured":"Hulleman, J. D., Balch, W. E. & Kelly, J. W. Translational attenuation differentially alters the fate of disease-associated fibulin proteins. FASEB J. 26, 4548\u20134560 (2012).","journal-title":"FASEB J."},{"key":"79570_CR31","doi-asserted-by":"publisher","first-page":"2423","DOI":"10.1093\/hmg\/ddm199","volume":"16","author":"LY Marmorstein","year":"2007","unstructured":"Marmorstein, L. Y., McLaughlin, P. J., Peachey, N. S., Sasaki, T. & Marmorstein, A. D. Formation and progression of sub-retinal pigment epithelium deposits in Efemp1 mutation knock-in mice: a model for the early pathogenic course of macular degeneration. Hum. Mol. Genet. 16, 2423\u20132432 (2007).","journal-title":"Hum. Mol. Genet."},{"key":"79570_CR32","doi-asserted-by":"publisher","first-page":"2411","DOI":"10.1093\/hmg\/ddm198","volume":"16","author":"L Fu","year":"2007","unstructured":"Fu, L. et al. The R345W mutation in EFEMP1 is pathogenic and causes AMD-like deposits in mice. Hum. Mol. Genet. 16, 2411\u20132422 (2007).","journal-title":"Hum. Mol. Genet."},{"key":"79570_CR33","doi-asserted-by":"publisher","first-page":"e0132529","DOI":"10.1371\/journal.pone.0132529","volume":"10","author":"DS Mackay","year":"2015","unstructured":"Mackay, D. S., Bennett, T. M. & Shiels, A. Exome sequencing identifies a missense variant in EFEMP1 co-segregating in a family with autosomal dominant primary open-angle glaucoma. PLoS ONE 10, e0132529 (2015).","journal-title":"PLoS ONE"},{"key":"79570_CR34","doi-asserted-by":"crossref","unstructured":"Bizzari, S. et al. Recessive marfanoid syndrome with herniation associated with a homozygous mutation in Fibulin-3. Eur. J. Med. Genet. 103869 (2020).","DOI":"10.1016\/j.ejmg.2020.103869"},{"key":"79570_CR35","doi-asserted-by":"publisher","first-page":"D980","DOI":"10.1093\/nar\/gkt1113","volume":"42","author":"MJ Landrum","year":"2014","unstructured":"Landrum, M. J. et al. ClinVar: public archive of relationships among sequence variation and human phenotype. Nucleic Acids Res. 42, D980-985 (2014).","journal-title":"Nucleic Acids Res."},{"key":"79570_CR36","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1096\/fj.14-255414","volume":"29","author":"JD Hulleman","year":"2015","unstructured":"Hulleman, J. D. & Kelly, J. W. Genetic ablation of N-linked glycosylation reveals two key folding pathways for R345W fibulin-3, a secreted protein associated with retinal degeneration. FASEB J. 29, 565\u2013575 (2015).","journal-title":"FASEB J."},{"key":"79570_CR37","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1110\/ps.041156905","volume":"14","author":"BK Ho","year":"2005","unstructured":"Ho, B. K., Coutsias, E. A., Seok, C. & Dill, K. A. The flexibility in the proline ring couples to the protein backbone. Prot. Sci. 14, 1011\u20131018 (2005).","journal-title":"Prot. Sci."},{"issue":"Pt 2","key":"79570_CR38","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1042\/bj2970249","volume":"297","author":"MP Williamson","year":"1994","unstructured":"Williamson, M. P. The structure and function of proline-rich regions in proteins. Biochem. J. 297(Pt 2), 249\u2013260 (1994).","journal-title":"Biochem. J."},{"key":"79570_CR39","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.exer.2014.12.002","volume":"130","author":"A Nguyen","year":"2015","unstructured":"Nguyen, A. & Hulleman, J. D. Differential tolerance of \u201cpseudo-pathogenic\u201d tryptophan residues in calcium-binding EGF domains of short fibulin proteins. Exp. Eye Res. 130, 66\u201372 (2015).","journal-title":"Exp. Eye Res."},{"key":"79570_CR40","doi-asserted-by":"publisher","first-page":"1939","DOI":"10.1167\/iovs.15-18789","volume":"57","author":"S Zadoo","year":"2016","unstructured":"Zadoo, S., Nguyen, A., Zode, G. & Hulleman, J. D. A novel luciferase assay for sensitively monitoring myocilin variants in cell culture. Investig. Ophthalmol. Vis. Sci. 57, 1939\u20131950 (2016).","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"79570_CR41","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1021\/cb900282e","volume":"5","author":"JN Burns","year":"2010","unstructured":"Burns, J. N. et al. Rescue of glaucoma-causing mutant myocilin thermal stability by chemical chaperones. ACS Chem. Biol. 5, 477\u2013487 (2010).","journal-title":"ACS Chem. Biol."},{"key":"79570_CR42","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1093\/hmg\/10.2.117","volume":"10","author":"N Jacobson","year":"2001","unstructured":"Jacobson, N. et al. Non-secretion of mutant proteins of the glaucoma gene myocilin in cultured trabecular meshwork cells and in aqueous humor. Hum. Mol. Genet. 10, 117\u2013125 (2001).","journal-title":"Hum. Mol. Genet."},{"key":"79570_CR43","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1093\/hmg\/ddh128","volume":"13","author":"Y Liu","year":"2004","unstructured":"Liu, Y. & Vollrath, D. Reversal of mutant myocilin non-secretion and cell killing: implications for glaucoma. Hum. Mol. Genet. 13, 1193\u20131204 (2004).","journal-title":"Hum. Mol. Genet."},{"key":"79570_CR44","doi-asserted-by":"publisher","first-page":"30469","DOI":"10.1074\/jbc.M403026200","volume":"279","author":"PA Klenotic","year":"2004","unstructured":"Klenotic, P. A., Munier, F. L., Marmorstein, L. Y. & Anand-Apte, B. Tissue inhibitor of metalloproteinases-3 (TIMP-3) is a binding partner of epithelial growth factor-containing fibulin-like extracellular matrix protein 1 (EFEMP1). Implications for macular degenerations. J. Biol. Chem. 279, 30469\u201330473 (2004).","journal-title":"J. Biol. Chem."},{"key":"79570_CR45","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1038\/ng1294-352","volume":"8","author":"BH Weber","year":"1994","unstructured":"Weber, B. H., Vogt, G., Pruett, R. C., Stohr, H. & Felbor, U. Mutations in the tissue inhibitor of metalloproteinases-3 (TIMP3) in patients with Sorsby\u2019s fundus dystrophy. Nat. Genet. 8, 352\u2013356 (1994).","journal-title":"Nat. Genet."},{"key":"79570_CR46","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.exer.2016.10.017","volume":"153","author":"JD Hulleman","year":"2016","unstructured":"Hulleman, J. D., Genereux, J. C. & Nguyen, A. Mapping wild-type and R345W fibulin-3 intracellular interactomes. Exp. Eye Res. 153, 165\u2013169 (2016).","journal-title":"Exp. Eye Res."},{"key":"79570_CR47","doi-asserted-by":"publisher","first-page":"e68088","DOI":"10.1371\/journal.pone.0068088","volume":"8","author":"MK Wyatt","year":"2013","unstructured":"Wyatt, M. K. et al. Interaction of complement factor h and fibulin3 in age-related macular degeneration. PLoS ONE 8, e68088 (2013).","journal-title":"PLoS ONE"},{"key":"79570_CR48","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1002\/path.5203","volume":"247","author":"M Tasaki","year":"2019","unstructured":"Tasaki, M. et al. A novel age-related venous amyloidosis derived from EGF-containing fibulin-like extracellular matrix protein 1. J. Pathol. 247, 444\u2013455 (2019).","journal-title":"J. Pathol."},{"key":"79570_CR49","doi-asserted-by":"publisher","first-page":"103869","DOI":"10.1016\/j.ejmg.2020.103869","volume":"63","author":"S Bizzari","year":"2020","unstructured":"Bizzari, S. et al. Recessive marfanoid syndrome with herniation associated with a homozygous mutation in Fibulin-3. Eur. J. Med. Genet. 63, 103869 (2020).","journal-title":"Eur. J. Med. Genet."},{"key":"79570_CR50","doi-asserted-by":"publisher","first-page":"5555","DOI":"10.1093\/hmg\/ddv287","volume":"24","author":"R Fernandez-Godino","year":"2015","unstructured":"Fernandez-Godino, R., Garland, D. L. & Pierce, E. A. A local complement response by RPE causes early-stage macular degeneration. Hum. Mol. Genet. 24, 5555\u20135569 (2015).","journal-title":"Hum. Mol. Genet."},{"key":"79570_CR51","doi-asserted-by":"publisher","first-page":"e0147684","DOI":"10.1371\/journal.pone.0147684","volume":"11","author":"A Nguyen","year":"2016","unstructured":"Nguyen, A. & Hulleman, J. D. Evidence of alternative cystatin C signal sequence cleavage which is influenced by the A25T polymorphism. PLoS ONE 11, e0147684 (2016).","journal-title":"PLoS ONE"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-79570-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-79570-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-79570-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T03:03:14Z","timestamp":1670036594000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-79570-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,4]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["79570"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-79570-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,4]]},"assertion":[{"value":"21 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 December 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2998"}}